Cited by 147vaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune Responses

The DOI matches its Crossref record; 94 of the 103 references it cites were found in a registry or an index, and 3 are not checked yet.

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Open access

Weingarten-Gabbay, Shira, Klaeger, Susan, Sarkizova, Siranush, Pearlman, Leah R., Chen, Da-Yuan, Gallagher, Kathleen M.E., Bauer, Matthew R., Taylor, Hannah B., Dunn, W. Augustine, Tarr, Christina, Sidney, John, Rachimi, Suzanna, Conway, Hasahn L., Katsis, Katelin, Wang, Yuntong, Leistritz-Edwards, Del, Durkin, Melissa R., Tomkins-Tinch, Christopher H., Finkel, Yaara, Nachshon, Aharon, Gentili, Matteo, Rivera, Keith D., Carulli, Isabel P., Chea, Vipheaviny A., Chandrashekar, Abishek, Bozkus, Cansu Cimen, Carrington, Mary, Lavin-Parsons, Kendall, Parry, Blair, Lilley, Brendan, Lodenstein, Carl, McKaig, Brenna, Charland, Nicole, Khanna, Hargun, Margolin, Justin, Gonye, Anna, Gushterova, Irena, Lasalle, Tom, Sharma, Nihaarika, Russo, Brian C., Rojas-Lopez, Maricarmen, Sade-Feldman, Moshe, Manakongtreecheep, Kasidet, Tantivit, Jessica, Fisher Thomas, Molly, Bhardwaj, Nina, Barouch, Dan H., Sette, Alessandro, Maus, Marcela V., Rice, Charles M., Clauser, Karl R., Keskin, Derin B., Pregibon, Daniel C., Hacohen, Nir, Carr, Steven A., Abelin, Jennifer G., Saeed, Mohsan, Sabeti, Pardis C.·2021·Cell

DOI 10.1016/j.cell.2021.05.046PMC PMC8173604

Open this paper in CoChat — free account

Abstract

T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and nucleocapsid not captured by current vaccines. Some peptides from out-of-frame ORFs elicited T cell responses in a humanized mouse model and individuals with COVID-19 that exceeded responses to canonical peptides, including some of the strongest epitopes reported to date. Whole-proteome analysis of infected cells revealed that early expressed viral proteins contribute more to HLA-I presentation and immunogenicity. These biological insights, as well as the discovery of out-of-frame ORF epitopes, will facilitate selection of peptides for immune monitoring and vaccine development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.05.046

Cites

94 of 97 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
The Perseus computational platform for comprehensive analysis of (prote)omics data
Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., & Cox, J. (2016) · Nature Methods · doi:10.1038/nmeth.3901 · Cited by 8,803
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Aran, D., Looney, A. P., Liu, L., Wu, E., Fong, V., Hsu, A., Chak, S., Naikawadi, R. P., Wolters, P. J., Abate, A. R., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0276-y · Cited by 4,984
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Self-citation
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304 · cited 1×
“For example, viruses can attenuate translation of host proteins, downregulate proteasome machinery, and interfere with HLA-I expression (Hansen and Bouvier, 2009; Sonenberg and Hinnebusch, 2009).”
Background
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · cited 1×
“In addition to the two current mRNA vaccines targeting the S glycoprotein (Callaway, 2020; Jackson et al., 2020; Mulligan et al., 2020), the N protein is also considered for vaccine development (Dutta et al.”
Background
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656
Self-citation
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS
Thompson, A., Schäfer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., Neumann, T., & Hamon, C. (2003) · Analytical Chemistry · doi:10.1021/ac0262560 · Cited by 2,425
Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Recovering Gene Interactions from Single-Cell Data Using Data Diffusion
van Dijk, D., Sharma, R., Nainys, J., Yim, K., Kathail, P., Carr, A. J., Burdziak, C., Moon, K. R., Chaffer, C. L., Pattabiraman, D., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.061 · Cited by 1,829
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Self-citation
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920
Self-citation
Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
Weiskopf, D., Schmitz, K. S., Raadsen, M. P., Grifoni, A., Okba, N. M. A., Endeman, H., van den Akker, J. P. C., Molenkamp, R., Koopmans, M. P. G., van Gorp, E. C. M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd2071 · Cited by 907
Self-citation
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Chen, R. E., Zhang, X., Case, J. B., Winkler, E. S., Liu, Y., VanBlargan, L. A., Liu, J., Errico, J. M., Xie, X., Suryadevara, N., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01294-w · Cited by 881
Efficient integration of heterogeneous single-cell transcriptomes using Scanorama
Hie, B., Bryson, B. D., & Berger, B. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0113-3 · Cited by 876
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 760
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706
Self-citation
Negligible impact of SARS-CoV-2 variants on CD4 + and CD8 + T cell reactivity in COVID-19 exposed donors and vaccinees
(2021) · doi:10.1101/2021.02.27.433180 · Cited by 706
Ribosome Profiling Reveals Pervasive Translation Outside of Annotated Protein-Coding Genes
Ingolia, N. T., Brar, G. A., Stern‐Ginossar, N., Harris, M. S., Talross, G. J. S., Jackson, S. E., Wills, M. R., & Weissman, J. S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.045 · Cited by 670
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Stukalov, A., Girault, V., Grass, V., Karayel, Ö., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03493-4 · Cited by 656
Pervasive functional translation of noncanonical human open reading frames
Chen, J., Brunner, A., Cogan, J. Z., Nuñez, J. K., Fields, A. P., Adamson, B., Itzhak, D. N., Li, J. Y., Mann, M., Leonetti, M. D., et al. (2020) · Science · doi:10.1126/science.aay0262 · Cited by 654
The coding capacity of SARS-CoV-2
Finkel, Y., Mizrahi, O., Nachshon, A., Weingarten-Gabbay, S., Morgenstern, D., Yahalom-Ronen, Y., Tamir, H., Achdout, H., Stein, D., Israeli, O., et al. (2021) · Nature · doi:10.1038/s41586-020-2739-1 · Cited by 644
Self-citation
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Abelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J. D., Lane, W. J., Zhang, G., Eisenhaure, T., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 607
Self-citation
SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
Schubert, K. N., Karousis, E. D., Jomaa, A., Scaiola, A., Echeverria, B., Gurzeler, L., Leibundgut, M., Thiel, V., Mühlemann, O., & Ban, N. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0511-8 · Cited by 605
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Su, Y., Chen, D., Yuan, D., Lausted, C. G., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R. S. K., Scherler, K., Troisch, P., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.037 · Cited by 605
Self-citation
Decoding Human Cytomegalovirus
Stern-Ginossar, N., Weisburd, B., Michalski, A., Le, V. T. K., Hein, M. Y., Huang, S.-X., Ma, M., Shen, B., Qian, S.-B., Hengel, H., et al. (2012) · Science · doi:10.1126/science.1227919 · Cited by 589
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024202118 · Cited by 553
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100204 · Cited by 540
Self-citation
The race for coronavirus vaccines: a graphical guide
Callaway, E. (2020) · Nature · doi:10.1038/d41586-020-01221-y · Cited by 492
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
Sarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 488
Self-citation
MHC class I antigen presentation: learning from viral evasion strategies
Hansen, T. H., & Bouvier, M. (2009) · Nature reviews. Immunology · doi:10.1038/nri2575 · Cited by 434
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
Wu, K., Werner, A. P., Koch, M., Choi, A., Narayanan, E., Stewart-Jones, G. B. E., Colpitts, T., Bennett, H., Boyoglu-Barnum, S., Shi, W., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102179 · Cited by 409
The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020) · Journal of Virology · doi:10.1128/jvi.00647-20 · Cited by 407
Balancing selection and heterogeneity across the classical human leukocyte antigen loci: A meta-analytic review of 497 population studies
Solberg, O. D., Mack, S. J., Lancaster, A. K., Single, R. M., Tsai, Y., Sanchez‐Mazas, A., & Thomson, G. J. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.001 · Cited by 345
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer
Ouspenskaia, T., Law, T. E., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01021-3 · Cited by 333
Self-citation
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 319
Self-citation
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein
Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318
Self-citation
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145476 · Cited by 261
Two complementary methods for predicting peptides binding major histocompatibility complex molecules
Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259
Self-citation
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis
Finkel, Y., Gluck, A., Nachshon, A., Winkler, R., Fisher, T., Rozman, B., Mizrahi, O., Lubelsky, Y., Zuckerman, B., Slobodin, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03610-3 · Cited by 253
Self-citation
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection
Altmann, D. M., & Boyton, R. J. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6160 · Cited by 243
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Shomuradova, A. S., Vagida, M. S., Sheetikov, S. A., Zornikova, K. V., Kiryukhin, D. O., Titov, A., Peshkova, I. O., Khmelevskaya, A. A., Dianov, D. V., Malasheva, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.004 · Cited by 230
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients
Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Hernandez, S. P. A., Nielsen, M., Gang, A. O., & Hadrup, S. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7550 · Cited by 226
Improved Ribo-seq enables identification of cryptic translation events
Erhard, F., Halenius, A., Zimmermann, C., L’Hernault, A., Kowalewski, D. J., Weekes, M. P., Stevanović, S., Zimmer, R., & Dölken, L. (2018) · Nature Methods · doi:10.1038/nmeth.4631 · Cited by 216
Most non-canonical proteins uniquely populate the proteome or immunopeptidome
Cuevas, M. V. R., Hardy, M., Hollý, J., Bonneil, É., Durette, C., Courcelles, M., Lanoix, J., Côté, C., Staudt, L. M., Lemieux, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108815 · Cited by 206
The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-IPreprint
Zhang, Y., Zhang, J., Chen, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.24.111823 · Cited by 192
High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
Chong, C., Marino, F., Pak, H., Racle, J., Daniel, R. T., Müller, M., Gfeller, D., Coukos, G., & Bassani‐Sternberg, M. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir117.000383 · Cited by 188
Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype
Habel, J. R., Nguyen, T. H. O., van de Sandt, C. E., Juno, J. A., Chaurasia, P., Wragg, K. M., Koutsakos, M., Hensen, L., Jia, X., Chua, B. Y. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015486117 · Cited by 183
Kinetics of Antigen Expression and Epitope Presentation during Virus Infection
Croft, N. P., Smith, S. A., Wong, Y. C., Tan, C. T., Dudek, N. L., Flesch, I. E. A., Lin, L. C. W., Tscharke, D. C., & Purcell, A. W. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003129 · Cited by 164
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint
Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147
Self-citation
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVPreprint
Stukalov, A., Girault, V., Grass, V., Karayel, O., Bergant, V., Urban, C., Haas, D. A., Huang, Y., Oubraham, L., Wang, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.17.156455 · Cited by 144
Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture
Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., & Sette, A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1803s100 · Cited by 133
Self-citation
Unsupervised HLA Peptidome Deconvolution Improves Ligand Prediction Accuracy and Predicts Cooperative Effects in Peptide–HLA Interactions
Bassani‐Sternberg, M., & Gfeller, D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600808 · Cited by 132
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121
Self-citation
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants
Redd, A. D., Nardin, A., Kared, H., Bloch, E. M., Pekosz, A. S., Laeyendecker, O. B., Abel, B., Fehlings, M., Quinn, T. C., & Tobian, A. A. R. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab143 · Cited by 105
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes
Poran, A., Harjanto, D., Malloy, M., Arieta, C. M., Rothenberg, D. A., Lenkala, D., van Buuren, M. M., Addona, T. A., Rooney, M. S., Srinivasan, L., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00767-w · Cited by 101
MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells
Altman, J. D., & Davis, M. M. (2016) · Current Protocols in Immunology · doi:10.1002/cpim.14 · Cited by 99
Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses
Wu, T., Guan, J. Z., Handel, A., Tscharke, D. C., Sidney, J., Sette, A., Wakim, L. M., Sng, X. Y. X., Thomas, P. G., Croft, N. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10661-8 · Cited by 98
Self-citation
Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine
Zhu, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.01.001 · Cited by 96
Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposurePreprint
Francis, J. M., Leistritz-Edwards, D., Dunn, A., Tarr, C., Lehman, J. W., Dempsey, C., Hamel, A., Rayon-Estrada, V., Liu, G., Wang, Y., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1126/sciimmunol.abk3070 · Cited by 90
Self-citation
On programmed ribosomal frameshifting: the alternative proteomes
Ketteler, R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00242 · Cited by 84
Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance
Starck, S. R., & Shastri, N. (2016) · Immunological Reviews · doi:10.1111/imr.12434 · Cited by 77
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes
McMurtrey, C., Lelic, A., Piazza, P. A., Chakrabarti, A. K., Yablonsky, E. J., Wahl, A. R., Bardet, W., Eckerd, A., Cook, R. L., Hess, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711874105 · Cited by 67
SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in CellsPreprint
Andres, A. D., Feng, Y., Campos, A. R., Yin, J., Yang, C.-C., James, B. P., Murad, R., Kim, H., Deshpande, A. J., Gordon, D. E., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.256776 · Cited by 67
CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variantsPreprint
Redd, A., Nardin, A., Kared, H., et al. (2021) · medRxiv · doi:10.1101/2021.02.11.21251585 · Cited by 65
Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells
Ternette, N., Yang, H., Partridge, T., Llano, A., Cedeño, S., Fischer, R., Charles, P. D., Dudek, N. L., Mothe, B., Casal, M. C., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545890 · Cited by 58
Immune evasion via SARS-CoV-2 ORF8 protein?
Park, M. D. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0360-z · Cited by 58
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution
Jungreis, I., Nelson, C. W., Ardern, Z., Finkel, Y., Krogan, N. J., Sato, K., Ziebuhr, J., Stern‐Ginossar, N., Pavesi, A., Firth, A. E., et al. (2021) · Virology · doi:10.1016/j.virol.2021.02.013 · Cited by 57
Self-citation
Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture
Lunemann, S., Schöbel, A., Kah, J., Fittje, P., Hölzemer, A., Langeneckert, A. E., Hess, L. U., Poch, T., Martrus, G., García-Beltrán, W. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.019 · Cited by 51
Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity
Keskin, D. B., Reinhold, B. B., Zhang, G., Ivanov, A. R., Karger, B. L., & Reinherz, E. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423482112 · Cited by 50
Self-citation
Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancerPreprint
Ouspenskaia, T., Law, T. E., Clauser, K. R., Klaeger, S., Sarkizova, S., Aguet, F., Li, B., Christian, E., Knisbacher, B. A., Le, P. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.12.945840 · Cited by 45
Self-citation
Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles.
Campbell, K. M., Steiner, G., Wells, D. K., Ribas, A., & Kalbasi, A. K. (2020) · eScholarship (California Digital Library) · doi:10.1101/2020.03.30.016931 · Cited by 39
Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features
Finkel, Y., Schmiedel, D., Tai-Schmiedel, J., Nachshon, A., Winkler, R., Dobešová, M., Schwartz, M., Mandelboim, O., & Stern‐Ginossar, N. (2020) · eLife · doi:10.7554/elife.50960 · Cited by 38
Self-citation
How ‘killer’ T cells could boost COVID immunity in face of new variants
Ledford, H. K. (2021) · Nature · doi:10.1038/d41586-021-00367-7 · Cited by 38
SARS -CoV-2 T-cell immunity to variants of concern following vaccinationPreprint
Gallagher, K., Leick, M. B., Larson, R. C., Berger, T. R., Katsis, K., Yam, J. Y., Brini, G., Grauwet, K., MGH COVID-19 Collection & Processing Team, & Maus, M. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.03.442455 · Cited by 32
Self-citation
Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation
Schellens, I. M. M., Meiring, H. D., Hoof, I., Spijkers, S., Poelen, M. C. M., den Brink, J. A. M. V. G.-V., Costa, A. I., Vennema, H., Keşmir, C., van Baarle, D., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00546 · Cited by 29
Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs
Yang, N., Gibbs, J. S., Hickman, H. D., Reynoso, G. V., Ghosh, A. K., Bennink, J. R., & Yewdell, J. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502303 · Cited by 28
Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome
Demmers, L. C., Heck, A. J. R., & Wu, W. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00821 · Cited by 27
Identification of HLA-A*02:01-Restricted Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 That May Be Natural Targets of CD8 + T Cell Recognition In Vivo
Takagi, A., & Matsui, M. (2020) · Journal of Virology · doi:10.1128/jvi.01837-20 · Cited by 25
CD8 + T Cell Recognition of Cryptic Epitopes Is a Ubiquitous Feature of AIDS Virus Infection
Maness, N. J., Walsh, A. D., Piaskowski, S. M., Furlott, J. R., Kolar, H. L., Bean, A. T., Wilson, N. A., & Watkins, D. I. (2010) · Journal of Virology · doi:10.1128/jvi.01419-10 · Cited by 22
Influenza A Virus Negative Strand RNA Is Translated for CD8+ T Cell Immunosurveillance
Hickman, H. D., Mays, J. W., Gibbs, J. S., Košík, I., Magadán, J. G., Takeda, K., Das, S. R., Reynoso, G. V., Ngudiankama, B. F., Wei, J., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800586 · Cited by 20
SARS-CoV-2 desensitizes host cells to interferon through inhibition of the JAK-STAT pathwayPreprint
Chen, D. W., Khan, N., Close, B. J., Goel, R. K., Blum, B. C., Tavares, A. H., Kenney, D., Conway, H. L., Ewoldt, J. K., Kapell, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.27.358259 · Cited by 20
Self-citation
Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses
Ručević, M., Kourjian, G., Boucau, J., Blatnik, R., García-Beltrán, W. F., Berberich, M. J., Walker, B. D., Riemer, A. B., & Gall, S. L. (2016) · Journal of Virology · doi:10.1128/jvi.00599-16 · Cited by 19
Untitled work
(2000) · doi:10.1002/1098-2272(200101)20:1

Flagged first, then by citations

6 of the 103 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Mulligan, 2020, Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, Nature, 586, 589, 10.1038/s41586-020-2639-4 · DOI · Paper page
Stukalov, 2020, Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV, bioRxiv

Sorted by citations

The T cell immune response against SARS-CoV-2
Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,243
COVID-19 mRNA vaccines: Platforms and current developments
Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308
Advances and Utility of the Human Plasma Proteome
Deutsch, E. W., Omenn, G. S., Sun, Z., Maes, M., Pernemalm, M., Palaniappan, K. K., Letunica, N., Vandenbrouck, Y., Brun, V., Tao, S., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00657 · Cited by 246
T Cell Responses to SARS-CoV-2
Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 191
Self-citation
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
Lim, J. M. E., Tan, A. T., Bert, N. L., Hang, S. K., Low, J. G. H., & Bertoletti, A. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220780 · Cited by 115

See all 147

Authors: Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., Sidney, J., Rachimi, S., Conway, H. L., Katsis, K., Wang, Y., Leistritz-Edwards, D., Durkin, M. R., Tomkins-Tinch, C. H., Finkel, Y., Nachshon, A., Gentili, M., Rivera, K. D., Carulli, I. P., Chea, V. A., Chandrashekar, A., Bozkus, C. C., Carrington, M., Lavin-Parsons, K., Parry, B., Lilley, B., Lodenstein, C., McKaig, B., Charland, N., Khanna, H., Margolin, J., Gonye, A., Gushterova, I., Lasalle, T., Sharma, N., Russo, B. C., Rojas-Lopez, M., Sade-Feldman, M., Manakongtreecheep, K., Tantivit, J., Fisher Thomas, M., Bhardwaj, N., Barouch, D. H., Sette, A., Maus, M. V., Rice, C. M., Clauser, K. R., Keskin, D. B., Pregibon, D. C., Hacohen, N., Carr, S. A., Abelin, J. G., Saeed, M., & Sabeti, P. C.
Affiliations: Broad Institute (US)
Harvard University (US)
La Jolla Institute for Immunology (US)
Boston University (US)
Massachusetts General Hospital (US)
Weizmann Institute of Science (IL)
Dana-Farber Cancer Institute (US)
Beth Israel Deaconess Medical Center (US)
Mount Sinai Hospital (US)
Ragon Institute of MGH, MIT and Harvard (US)
Rockefeller University (US)
Corresponding author: Weingarten-Gabbay, Shira
Klaeger, Susan
Saeed, Mohsan
ORCID: Weingarten-Gabbay, Shira
Klaeger, Susan
Sarkizova, Siranush
Gallagher, Kathleen M.E.
Bauer, Matthew R.
Taylor, Hannah B.
Sidney, John
Rachimi, Suzanna
Conway, Hasahn L.
Leistritz-Edwards, Del
Durkin, Melissa R.
Tomkins-Tinch, Christopher H.
Finkel, Yaara
Nachshon, Aharon
Gentili, Matteo
Rivera, Keith D.
Carulli, Isabel P.
Chea, Vipheaviny A.
Chandrashekar, Abishek
Bozkus, Cansu Cimen
Carrington, Mary
Parry, Blair
Lilley, Brendan
McKaig, Brenna
Charland, Nicole
Khanna, Hargun
Margolin, Justin
Gonye, Anna
Gushterova, Irena
Russo, Brian C.
Sade-Feldman, Moshe
Manakongtreecheep, Kasidet
Tantivit, Jessica
Bhardwaj, Nina
Barouch, Dan H.
Sette, Alessandro
Maus, Marcela V.
Rice, Charles M.
Clauser, Karl R.
Keskin, Derin B.
Pregibon, Daniel C.
Hacohen, Nir
Carr, Steven A.
Abelin, Jennifer G.
Saeed, Mohsan
Sabeti, Pardis C.
Venue: Cell
Publisher: Elsevier BV
Published: 2021-07
Volume: 184
Issue: 15
Pages: 3962-3980.e17
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2021.05.046
PMC: PMC8173604
OpenAlex: W3172192134
Cited by: 147
References: 103
Citations by year: 2026: 6 · 2025: 23 · 2024: 32 · 2023: 38 · 2022: 33 · 2021: 15
FWCI: 9.26
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Cell (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (U24-CA210986, U24CA210979, U01 CA214125)
NIAID (U19AI110818, 3 R01-AI091707-10S1, U19AI082630)
Cancer Research Institute
Parker Institute for Cancer Immunotherapy
Broad Institute
Frederick National Laboratory for Cancer Research (HHSN261200800001E)
Human Frontier Science Program (LT-000396/2018)
European Molecular Biology Organization (ALTF 883-2017)
Iran National Science Foundation (CRI2993, 1745303, R21 CA216772-01A1, ALTF 486-2018)
Harvard University
Gilead Sciences
National Institutes of Health
G. Harold and Leila Y. Mathers Charitable Foundation
Novartis
Neos Therapeutics
U.S. Department of Health and Human Services
Massachusetts Institute of Technology
Boston University
BioMarin Pharmaceutical
Pfizer
Celldex Therapeutics
Biogen
Government of South Australia
Exelixis
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: SARS-CoV-2, T cell epitopes, viral peptide presentation, spike protein, nucleocapsid protein, T cell immunity, humanized mice, COVID-19 pandemic, vaccine development, early viral proteins
MeSH terms: A549 Cells, COVID-19, SARS-CoV-2, Alleles, Amino Acid Sequence, Animals, Female, Humans, Kinetics, Male, Peptides, T-Lymphocytes, Histocompatibility Antigens Class I, Open Reading Frames, Antigen Presentation, Epitopes, T-Lymphocyte, Proteome, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks